Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing Notch1 degradation and downregulating key vasculogenic genes
- 27 September 2023
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 217, 115833
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylationOncogene, 2014
- Notch pathway activation is associated with pancreatic cancer treatment failurePancreatology, 2014
- Multiple biological functions and pharmacological effects of lycorineScience China Chemistry, 2013
- Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicityToxicology Letters, 2013
- Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type IIArchives of Gynecology and Obstetrics, 2013
- RETRACTED: Notch-1 induces epithelial–mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cellsCancer Letters, 2011
- The E3 ligase Itch is a negative regulator of the homeostasis and function of hematopoietic stem cellsNature Immunology, 2011
- Regulation of the Embryonic Morphogen Nodal by Notch4 Facilitates Manifestation of the Aggressive Melanoma PhenotypeCancer Research, 2010
- Valproic Acid Induces Notch1 Signaling in Small Cell Lung Cancer CellsJournal of Surgical Research, 2008
- Valproic Acid Activates Notch1 Signaling and Induces Apoptosis in Medullary Thyroid Cancer CellsAnnals of Surgery, 2008